Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03533348
Other study ID # 0167-17-EMC
Secondary ID
Status Completed
Phase
First received
Last updated
Start date July 31, 2018
Est. completion date October 10, 2019

Study information

Verified date October 2019
Source HaEmek Medical Center, Israel
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The study aims to determine whether there is a need for preparative fasting prior to contrast-enhanced computed tomography (CT).


Description:

The use of fasting orders for imaging and other procedures is common, this seemingly benign practice can lead to real harms to patients and poor satisfaction with their care. The nothing per os (NPO) order is sometimes used in CT scans because gastrointestinal tract contents can interrupt visualization of the intestinal lumen, but more commonly NPO orders are are thought to protect all supine patients from aspiration during delivery of intravenous contrast. There is limited evidence to support such practice of NPO orders prior to contrast-enhanced CT scans. The authors' main objective is to determine if there is a need for preparative fasting prior to contrast-enhanced CT scans.


Recruitment information / eligibility

Status Completed
Enrollment 2148
Est. completion date October 10, 2019
Est. primary completion date October 10, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients undergoing contrast-enhanced CT scans

Exclusion Criteria:

1. Pateints undergoing CT scans while sedated.

2. Patients under the age of 18 years

3. Patients who suffer from a mental disorder that prevents them:

1. from understanding what s/he consents to and/ or

2. from choosing decisively and/ or

3. from communicating his/her consent

4. Patients who were instructed not to eat due to requirements of a specific study (for example.. computed tomography enterography-CTE)

Study Design


Related Conditions & MeSH terms

  • X-ray Contrast Media Adverse Reaction

Locations

Country Name City State
Israel Emek Medical Center Afula

Sponsors (1)

Lead Sponsor Collaborator
HaEmek Medical Center, Israel

Country where clinical trial is conducted

Israel, 

Outcome

Type Measure Description Time frame Safety issue
Primary Aspiration pneumonitis Rates of aspiration pneumonitis after contrast-enhanced CT scans Day 1
Secondary Gastrointestinal symptoms Rates of nausea and vomiting after contrast-enhanced CT scans Hour 1
See also
  Status Clinical Trial Phase
Completed NCT02449317 - Bioimpedance Analysis Guided Volume Expansion for the Prevention of Contrast Induced-acute Kidney Injury N/A